Walleye Trading’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-829,700
| Closed | -$70.5M | – | 4925 |
|
|
2019
Q4 | $70.5M | Buy |
829,700
+819,000
| +7,654% | +$54.6M | 0.49% | 14 |
|
|
2019
Q3 | $535K | Sell |
10,700
-109,200
| -91% | -$4.36M | ﹤0.01% | 2097 |
|
|
2019
Q2 | $4.37M | Buy |
119,900
+97,400
| +433% | +$3.18M | 0.04% | 523 |
|
|
2019
Q1 | $629K | Buy |
22,500
+15,900
| +241% | +$375K | ﹤0.01% | 2066 |
|
|
2018
Q4 | $126K | Sell |
6,600
-1,700
| -20% | -$39.5K | ﹤0.01% | 3758 |
|
|
2018
Q3 | $248K | Sell |
8,300
-7,600
| -48% | -$286K | ﹤0.01% | 3590 |
|
|
2018
Q2 | $584K | Sell |
15,900
-300
| -2% | -$9.75K | ﹤0.01% | 2687 |
|
|
2018
Q1 | $534K | Buy |
16,200
+12,100
| +295% | +$378K | ﹤0.01% | 2598 |
|
|
2017
Q4 | $113 | Sell |
4,100
-4,500
| -52% | -$139K | ﹤0.01% | 3780 |
|
|
2017
Q3 | $319 | Buy |
8,600
+1,800
| +26% | +$66.4K | ﹤0.01% | 2870 |
|
|
2017
Q2 | $259 | Sell |
6,800
-3,000
| -31% | -$134K | ﹤0.01% | 2928 |
|
|
2017
Q1 | $480 | Buy |
9,800
+7,900
| +416% | +$360K | ﹤0.01% | 2268 |
|
|
2016
Q4 | $65K | Sell |
1,900
-3,000
| -61% | -$106K | ﹤0.01% | 3504 |
|
|
2016
Q3 | $186K | Buy |
4,900
+2,100
| +75% | +$79.1K | ﹤0.01% | 2862 |
|
|
2016
Q2 | $94K | Buy |
2,800
+200
| +8% | +$7.05K | ﹤0.01% | 3564 |
|
|
2016
Q1 | $82K | Buy |
2,600
+1,400
| +117% | +$45.7K | ﹤0.01% | 3513 |
|
|
2015
Q4 | $45K | Sell |
1,200
-5,200
| -81% | -$197K | ﹤0.01% | 3940 |
|
|
2015
Q3 | $244K | Buy |
+6,400
| New | +$225K | ﹤0.01% | 2189 |
|
Other funds holding MDCO
Walleye Trading's MDCO Position: Q1 2020 in Review
Walleye Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 350,318 shares — an estimated $29.8M sold.
Walleye Trading first reported a position in MDCO in Q1 2015 and held it in 8 quarters. The position peaked at $29.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Walleye Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Walleye Trading sold 350,318 Medicines Co shares in Q1 2020, an estimated $29.8M.
- Walleye Trading first reported a position in Medicines Co in Q1 2015 and held it in 8 quarters.
- Walleye Trading's Medicines Co position peaked at $29.8M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.